BlackRock Fund Advisors - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 113 filers reported holding GW PHARMACEUTICALS PLC in Q3 2015. The put-call ratio across all filers is 2.38 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2016$29,513,000
+7.3%
264,098
+27.4%
0.01%
-16.7%
Q3 2016$27,511,000
+51.8%
207,274
+4.7%
0.01%
+50.0%
Q2 2016$18,121,000
+26.1%
197,888
-0.7%
0.00%
+33.3%
Q1 2016$14,376,000
+19.3%
199,247
+14.9%
0.00%0.0%
Q4 2015$12,047,000
-37.6%
173,481
-17.9%
0.00%
-40.0%
Q3 2015$19,317,000
+2.5%
211,420
+37.8%
0.01%0.0%
Q2 2015$18,852,000
+40.7%
153,470
+4.4%
0.01%
+66.7%
Q1 2015$13,394,000
+42.2%
146,982
+5.6%
0.00%
+50.0%
Q4 2014$9,420,000139,1900.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2015
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders